Quentin Sabbagh,Sadegheh Haghshenas,Juliette Piard,Chloé Trouvé,Jeanne Amiel,Tania Attié-Bitach,Tugce Balci,Mouna Barat-Houari,Alyce Belonis,Odile Boute,Diana S Brightman,Ange-Line Bruel,Stefano Giuseppe Caraffi,Nicolas Chatron,Corinne Collet,William Dufour,Patrick Edery,Chin-To Fong,Carlo Fusco,Vincent Gatinois,Evan Gouy,Anne-Marie Guerrot,Solveig Heide,Aakash Joshi,Natalya Karp,Boris Keren,Marion Lesieur-Sebellin,Jonathan Levy,Michael A Levy,Claire Lozano,Stanislas Lyonnet,Henri Margot,Pauline Marzin,Haley McConkey,Vincent Michaud,Gaël Nicolas,Mevyn Nizard,Alix Paulet,Francesca Peluso,Vincent Pernin,Laurence Perrin,Christophe Philippe,Chitra Prasad,Madhavi Prasad,Raissa Relator,Marlène Rio,Sophie Rondeau,Valentin Ruault,Nathalie Ruiz-Pallares,Elodie Sanchez,Debbie Shears,Victoria Mok Siu,Arthur Sorlin,Matthew Tedder,Mylène Tharreau,Frédéric Tran Mau-Them,Liselot van der Laan,Julien Van Gils,Alain Verloes,Sandra Whalen,Marjolaine Willems,Kévin Yauy,Roberta Zuntini,Jennifer Kerkhof,Bekim Sadikovic,David Geneviève,Diana S. Brightman,Michael A. Levy

Abstract:PURPOSE: BCL11B-related disorder (BCL11B-RD) arises from rare genetic variants within the BCL11B gene, resulting in a distinctive clinical spectrum encompassing syndromic neurodevelopmental disorder, with or without intellectual disability, associated with facial features and impaired immune function. This study presents an in-depth clinico-biological analysis of 20 newly reported individuals with BCL11B-RD, coupled with a characterization of genome-wide DNA methylation patterns of this genetic condition.METHODS: Through an international collaboration, clinical and molecular data from 20 individuals were systematically gathered, and a comparative analysis was conducted between this series and existing literature. We further scrutinized peripheral blood DNA methylation profile of individuals with BCL11B-RD, contrasting them with healthy controls and other neurodevelopmental disorders marked by established episignature.RESULTS: Our findings unveil rarely documented clinical manifestations, notably including Rubinstein-Taybi-like facial features, craniosynostosis, and autoimmune disorders, all manifesting within the realm of BCL11B-RD. We refine the intricacies of T cell compartment alterations of BCL11B-RD, revealing decreased levels naive CD4<sup>+</sup> T cells and recent thymic emigrants while concurrently observing an elevated proportion of effector-memory expressing CD45RA CD8<sup>+</sup> T cells (TEMRA). Finally, a distinct DNA methylation episignature exclusive to BCL11B-RD is unveiled.CONCLUSION: This study serves to enrich our comprehension of the clinico-biological landscape of BCL11B-RD, potentially furnishing a more precise framework for diagnosis and follow-up of individuals carrying pathogenic BCL11B variant. Moreover, the identification of a unique DNA methylation episignature offers a valuable diagnosis tool for BCL11B-RD, thereby facilitating routine clinical practice by empowering physicians to reevaluate variants of uncertain significance within the BCL11B gene.

Blepharophimosis with intellectual disability and Helsmoortel‐Van Der Aa Syndrome share episignature and phenotype

The detection of a strong episignature for Chung–Jansen syndrome, partially overlapping with Börjeson–Forssman–Lehmann and White–Kernohan syndromes

Extended phenotypic characterization of a novel Helsmoortel‐van der Aa syndrome case series

[Analysis of FOXL2 Gene Mutations in 5 Families Affected with Blepharophimosis, Ptosis and Epicanthus Inversus Syndrome].

Simpson–Golabi–Behmel syndrome

Helsmoortel-Van der Aa syndrome in a 13-year-old girl with autistic spectrum disorder, dysmorphism, a right solitary kidney, and polycystic ovaries: a case report

Phenotypic and genetic analysis of a child with blepharophimosis, ptosis, epicanthus inverses syndrome and tetralogy of Fallot

Expanded phenotypic spectrum of neurodevelopmental and neurodegenerative disorder Bryant-Li-Bhoj syndrome with 38 additional individuals

Clinico-biological refinement of BCL11B-related disorder and identification of an episignature: A series of 20 unreported individuals

Cat eye syndrome: Clinical, cytogenetics and familial findings in a large cohort of 43 patients highlighting the importance of congenital heart disease and inherited cases

Phenotypic expansion of Bosch–Boonstra–Schaaf optic atrophy syndrome and further evidence for genotype–phenotype correlations

Comprehensive EHMT1 variants analysis broadens genotype-phenotype associations and molecular mechanisms in Kleefstra syndrome

A severe case of Frank-ter Haar syndrome and literature review: Further delineation of the phenotypical spectrum

Epigenomic and phenotypic characterization of DEGCAGS syndrome

Comprehensive study of 28 individuals with SIN3A-related disorder underscoring the associated mild cognitive and distinctive facial phenotype

Widening of the genetic and clinical spectrum of Lamb-Shaffer syndrome, a neurodevelopmental disorder due to SOX5 haploinsufficiency

Bi-allelic loss-of-function variants in TMEM147 cause moderate to profound intellectual disability with facial dysmorphism and pseudo-Pelger-Huët anomaly

SCYL2‐related autosomal recessive neurodevelopmental disorders: Arthrogryposis multiplex congenita‐4 and beyond?

Biallelic pathogenic variants in the lanosterol synthase gene LSS involved in the cholesterol biosynthesis cause alopecia with intellectual disability, a rare recessive neuroectodermal syndrome

Biallelic loss-of-function variants in CACHD1 cause a novel neurodevelopmental syndrome with facial dysmorphism and multisystem congenital abnormalities

Further description of two individuals with de novo p.(Glu127Lys) missense variant in the ASCL1 gene